Malta - English - Medicines Authority

bausch + lomb ireland limited 3013 lake drive citywest business campus dublin 24, d24ppt, ireland - azelastine hydrochloride - nasal spray, solution - azelastine hydrochloride 0.14 mg - nasal preparations

Malta - English - Medicines Authority

viatris healthcare limited damastown industrial park, mulhuddart, dublin 15, dublin , ireland - nasal spray, suspension - azelastine hydrochloride 137 µg/spray fluticasone propionate 50 µg/spray - nasal preparations

Malta - English - Medicines Authority

zentiva k.s. u kabelovny 130, dolní mecholupy, 102 37 praha 10, czech republic - nasal spray, solution - azelastine hydrochloride 1 mg - nasal preparations

Singapore - English - HSA (Health Sciences Authority)

glaxosmithkline pte ltd - fluticasone furoate (micronised) - spray, suspension - 0.0275mg/spray - fluticasone furoate (micronised) 0.0275mg/spray

Australia - English - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - fluticasone furoate, quantity: 27.5 microgram - spray, suspension - excipient ingredients: purified water; disodium edetate; polysorbate 80; dispersible cellulose; glucose; benzalkonium chloride - for the treatment of seasonal allergic rhinitis and perennial allergic rhinitis in adults and children of ages 2 years and older.

Australia - English - Department of Health (Therapeutic Goods Administration)

organon pharma pty ltd - mometasone furoate, quantity: 50 microgram/actuation - spray, suspension - excipient ingredients: dispersible cellulose; citric acid monohydrate; glycerol; purified water; benzalkonium chloride; citric acid; sodium citrate dihydrate; polysorbate 80 - for the treatment of symptoms associated with seasonal allergic rhinitis and perennial allergic rhinitis and the prophylaxis of seasonal allergic rhinitis in adults, adolescents and children between the ages of 3 and 11 years. the treatment of nasal polyps in adult patients 18 years of age and older. for the treatment of symptoms associated with acute rhinosinusitis in patients 12 years of age and older without the signs and symptoms of severe bacterial infection.

Australia - English - Department of Health (Therapeutic Goods Administration)

johnson & johnson pacific pty ltd - budesonide, quantity: 1.28 mg/ml - spray, suspension - excipient ingredients: potassium sorbate; polysorbate 80; disodium edetate; hydrochloric acid; purified water; dispersible cellulose; glucose - rhinitis: prophylaxis and treatment of seasonal allergic rhinitis. prophylaxis and treatment of perennial allergic rhinitis. nasal polyps: treatment of nasal polyps.

Australia - English - Department of Health (Therapeutic Goods Administration)

johnson & johnson pacific pty ltd - budesonide, quantity: 1.28 mg/ml - spray, suspension - excipient ingredients: glucose; disodium edetate; dispersible cellulose; polysorbate 80; purified water; hydrochloric acid; potassium sorbate - rhinitis: prophylaxis and treatment of seasonal allergic rhinitis. prophylaxis and treatment of perennial allergic rhinitis. nasal polyps: treatment of nasal polyps.

Australia - English - Department of Health (Therapeutic Goods Administration)

johnson & johnson pacific pty ltd - budesonide, quantity: 0.64 mg/ml - spray, suspension - excipient ingredients: potassium sorbate; glucose; dispersible cellulose; hydrochloric acid; disodium edetate; polysorbate 80; purified water - rhinitis: prophylaxis and treatment of seasonal allergic rhinitis. prophylaxis and treatment of perennial allergic rhinitis. nasal polyps: treatment of nasal polyps.

Australia - English - Department of Health (Therapeutic Goods Administration)

johnson & johnson pacific pty ltd - budesonide, quantity: 0.64 mg/ml - spray, suspension - excipient ingredients: potassium sorbate; disodium edetate; glucose; purified water; hydrochloric acid; dispersible cellulose; polysorbate 80 - rhinitis: prophylaxis and treatment of seasonal allergic rhinitis. prophylaxis and treatment of perennial allergic rhinitis. nasal polyps: treatment of nasal polyps.